Tirbanibulin
| CAS No. | 897016-82-9 |
|---|---|
| MDL No. | MFCD18633218 |
| MF | C26H29N3O3 |
| MW | 431.50 |
| InChI Key | HUNGUWOZPQBXGX-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Tirbanibulin is a pyridine derivative substituted at positions 2 and 5 with 2-(benzylamino)-2-oxoethyl and 4-[2-(morpholin-4-yl)ethoxy]phenyl groups, respectively. It is a dual inhibitor of Src kinase and tubulin, approved by the FDA for topical treatment of actinic keratosis on the face or scalp. It functions as an antineoplastic agent, apoptosis inducer, non-specific protein-tyrosine kinase inhibitor, and microtubule-destabilizing agent. It belongs to the classes of morpholines, aromatic ethers, pyridines, and secondary carboxamides.
| CAS No. | 897016-82-9 |
|---|---|
| Product Name | Tirbanibulin |
Biological Targets
SRC
Associated Conditions
lymphoma·acute myeloid leukemia·basal cell carcinoma·neoplasm·prostate cancer·
* The information provided here is compiled from public sources and is for reference only.
